Decoding DOJ’s Crackdown on Genetic Testing: High-Profile Indictments and Practical Takeaways for the Cancer and Pharma Genomics Industries

Published date25 March 2020
Subject MatterDOJ,Medicare,Kickbacks,Telemedicine,DNA,FBI,Healthcare Fraud,Cancer,DEA,Medical Research,Guilty Pleas,Genetic Testing,Indictments,Prescribing Authority,Criminal Investigations,Fraudulent Marketing,Unnecessary Medical Procedures
AuthorGiovanni Giarratana,Somadina Nwokolo
Law FirmBradley Arant Boult Cummings LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT